TIGIT regulates CD4+ T cell immunity against polymicrobial sepsis
ConclusionTIGIT modulates CD4+ T cell response against polymicrobial sepsis, suggesting that TIGIT could serve as a potential therapeutic target for sepsis.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: Allergy & Immunology | Health Management | Intensive Care | Liver | Study | Urology & Nephrology